Betel Extract for Treatment of Different Malignancies
The present technology provides use of extract of Piper betel leaves along with pharmaceuticals acceptable additives for the treatment of human malignancies (several kind of cancers) of different origin by inducing oxidative stress. The said extract induces the elevation of ROS preferentially in the cancer cells thereby causing cytotoxicity and eventually death of these cells. Being specific to high ROS it only targets the cancer cells and doesn’t harm the normal cells of the body. The said extract in form of a composition can be administered through oral, intravenous, intramuscular or subcutaneous route. The technology has shown proven efficacy in the in-vivo testing on nude mices and found to induce apoptosis and necrosis in the cancer cells.
Sector: Pharmaceuticals
Country: India
Area of Application: medical industry.
Keywords: malignancies,aromatic stimulant and anti-flatulent.
Advantages: Use of betel leaves in treating cancer is a novel feature. Doesn’t shows any side-effects to normal cells. The technology can be used for treating many kind of cancers. Induces apoptosis and necrosis preferentially in cancer cells. In-vivo studies on rats shows proven efficacy.
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent in Progress
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054